---
layout: minimal
nav_exclude: true
title: Dexamethasone Intravitreal Implant
---

# Dexamethasone Intravitreal Implant

**Generic Name:** Dexamethasone Intravitreal Implant

**Usage:**

Dexamethasone intravitreal implant is used to treat macular edema (swelling of the macula, the central part of the retina) following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).  It's also used to treat non-infectious uveitis (inflammation of the uvea, the middle layer of the eye) affecting the posterior segment (back of the eye).  The implant delivers a sustained release of dexamethasone, a corticosteroid, directly into the vitreous humor (the gel-like substance filling the eye).  This targeted delivery reduces the need for frequent injections compared to other treatments.  It is typically implanted during a minor surgical procedure.

**Side Effects:**

Common side effects can include:

* **Increased intraocular pressure (IOP):** This is a significant risk and requires close monitoring with regular IOP measurements.  Treatment for elevated IOP may be necessary.
* **Cataracts:**  Dexamethasone can accelerate cataract formation or worsen pre-existing cataracts.
* **Glaucoma:**  Increased IOP can lead to glaucoma.
* **Elevated blood sugar (hyperglycemia):** Particularly a concern for patients with diabetes.
* **Infection:**  As with any intraocular procedure, there is a risk of infection.
* **Retinal tear or detachment:** Although rare, this is a potential complication.
* **Endophthalmitis:** A serious infection inside the eye.
* **Increased risk of bleeding** in the eye (especially if the patient has diabetic retinopathy)
* **Thinning of the retina**


Less common side effects may also occur.  It's crucial to report any changes in vision or eye discomfort to the ophthalmologist immediately.

**How it Works:**

Dexamethasone is a potent corticosteroid that reduces inflammation in the eye. By implanting a sustained-release device into the vitreous, the medication is delivered directly to the affected area over an extended period (typically 6-8 months, though duration depends on the implant design). This targeted delivery reduces inflammation, thus decreasing macular edema and improving vision.  The mechanism of action involves suppressing the inflammatory cascade, reducing the production of inflammatory mediators.

**FAQs:**

* **How long does the implant last?**  The duration of effect varies depending on the specific implant design and individual patient response, but generally ranges from 6 to 8 months.
* **Is surgery required for implantation?** Yes, a minor surgical procedure is necessary to implant the device.
* **What are the follow-up appointments like?** Regular follow-up appointments are crucial to monitor intraocular pressure, assess the implant's position and efficacy, and check for any complications.
* **Are there alternatives to this treatment?** Yes, other treatments for macular edema and uveitis include intravitreal injections of corticosteroids, anti-VEGF medications, and laser photocoagulation.
* **What should I do if I experience vision changes or eye pain after implantation?** Contact your ophthalmologist immediately.
* **Can I drive after the procedure?** Driving may be restricted until your vision has stabilized after the procedure and any potential side effects have been assessed by your doctor.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a qualified ophthalmologist or healthcare professional for any concerns about your eye health and treatment options.  The specific side effects and duration of action may vary based on the brand and specific formulation of the Dexamethasone intravitreal implant.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.